| Patent | Date |
|---|
Enzyme Inhibitors
App 20220298138 - DAVIE; Rebecca Louise ; et al. | 2022-09-22 |
Enzyme Inhibitors
App 20220298141 - DAVIE; Rebecca Louise ; et al. | 2022-09-22 |
N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors
App 20220289729 - Davie; Rebecca Louise ; et al. | 2022-09-15 |
Enzyme Inhibitors
App 20220289727 - CHILDS; Mitchell Lewis ; et al. | 2022-09-15 |
Enzyme Inhibitors
App 20220048894 - DAVIE; Rebecca Louise ; et al. | 2022-02-17 |
Enzyme Inhibitors
App 20220002275 - Davie; Rebecca Louise ; et al. | 2022-01-06 |
N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
Grant 11,198,691 - Davie , et al. December 14, 2 | 2021-12-14 |
Pyrazole derivatives as plasma kallikrein inhibitors
Grant 11,180,484 - Davie , et al. November 23, 2 | 2021-11-23 |
N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
Grant 11,084,809 - Davie , et al. August 10, 2 | 2021-08-10 |
Chemical Compounds
App 20210238162 - CADILLA; Rodolfo ; et al. | 2021-08-05 |
N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
Grant 11,001,578 - Davie , et al. May 11, 2 | 2021-05-11 |
N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors
App 20200361923 - Davie; Rebecca Louise ; et al. | 2020-11-19 |
N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
Grant 10,781,181 - Evans , et al. Sept | 2020-09-22 |
N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors
App 20200199116 - Davie; Rebecca Louise ; et al. | 2020-06-25 |
N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
Grant 10,611,758 - Davie , et al. | 2020-04-07 |
N-((het)arylmethyl)-heteroaryl-carboxamides Compounds As Kallikrein Inhibitors
App 20190330200 - Davie; Rebecca Louise ; et al. | 2019-10-31 |
N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Plasma Kallikrein Inhibitors
App 20190300517 - Davie; Rebecca Louise ; et al. | 2019-10-03 |
N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
Grant 10,364,238 - Davie , et al. | 2019-07-30 |
Pyrazole Derivatives As Plasma Kallikrein Inhibitors
App 20190218205 - DAVIE; Rebecca Louise ; et al. | 2019-07-18 |
N-((het) Arylmethyl)-heteroaryl-carboxamides Compounds As Plasma Kallikrein Inhibitors
App 20180319782 - DAVIE; Rebecca Louise ; et al. | 2018-11-08 |
N-((het) Arylmethyl)-heteroaryl-carboxamides Compounds As Plasma Kallikrein Inhibitors
App 20170305863 - EVANS; David Michael ; et al. | 2017-10-26 |
Heterocyclic derivates
Grant 9,533,987 - Davie , et al. January 3, 2 | 2017-01-03 |
Heterocyclic Derivates
App 20160108036 - DAVIE; Rebecca Louise ; et al. | 2016-04-21 |
Compounds
Grant 8,507,543 - Hodgson , et al. August 13, 2 | 2013-08-13 |
Novel Compounds
App 20130030031 - HODGSON; Simon Teanby ; et al. | 2013-01-31 |
Pyrazole derivatives used as CCR4 receptor antagonists
Grant 8,357,716 - Hobbs , et al. January 22, 2 | 2013-01-22 |
Compounds
Grant 8,304,446 - Hodgson , et al. November 6, 2 | 2012-11-06 |
Pyrazole Derivatives Used as CCR4 Receptor Antagonists
App 20120015932 - Hobbs; Heather ; et al. | 2012-01-19 |
Substituted Quinoline Derivatives As H1 Receptor Antagonists
App 20110281909 - Gore; Paul Martin ; et al. | 2011-11-17 |
3-(4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] oxy} phenyl)-1-piperidinyl] carbonyl}-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
Grant 7,989,629 - Hodgson , et al. August 2, 2 | 2011-08-02 |
Compounds
Grant 7,884,114 - Gore , et al. February 8, 2 | 2011-02-08 |
Quinoline Derivatives Used To Treat Inflammatory And Allergic Diseases
App 20100222349 - Gore; Paul Martin ; et al. | 2010-09-02 |
Novel Compounds
App 20100216860 - Hodgson; Simon Teanby ; et al. | 2010-08-26 |
Substituted Piperazines, (1,4) Diazepines, And 2,5-diazabicyclo (2.2.1) Heptanes As Histamine H1 And/or H3 Antagonists Or Histamine H3 Reverse Antagonists
App 20100075953 - Ancliff; Rachael ; et al. | 2010-03-25 |
Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
Grant 7,622,464 - Ancliff , et al. November 24, 2 | 2009-11-24 |
Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists
Grant 7,615,550 - Heightman , et al. November 10, 2 | 2009-11-10 |
Compounds
App 20090270355 - Gore; Paul Martin ; et al. | 2009-10-29 |
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
Grant 7,560,548 - Ancliff , et al. July 14, 2 | 2009-07-14 |
Morpholin-acetamide Derivatives For The Treatment Of Inflammatory Diseases
App 20090163495 - Ancliff; Rachael Anne ; et al. | 2009-06-25 |
2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists
App 20090105225 - Gore; Paul Martin ; et al. | 2009-04-23 |
3- (4-{ [4- (4-{ [3-(3, 3-Dimethyl-1-Piperidinyl) Propyl] Oxy} Phenyl) -1-Piperidinyl] Carbonyl}-1-Naphthalenyl) Propanoic or Propenoic Acid as H1 and H3 Receptor Antagonists for the Treatment of Inflammatory and/or Allergic Disorders
App 20080312280 - Hodgson; Simon Teanby ; et al. | 2008-12-18 |
Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists
App 20080275027 - Ancliff; Rachael Ann ; et al. | 2008-11-06 |
Compounds
App 20080207638 - Ancliff; Rachael Ann ; et al. | 2008-08-28 |
Compounds
App 20080039444 - GORE; Paul Martin ; et al. | 2008-02-14 |
Compounds useful in the treatment of inflammatory diseases
Grant 7,157,457 - Ancliff , et al. January 2, 2 | 2007-01-02 |
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
Grant 7,101,882 - Ancliff , et al. September 5, 2 | 2006-09-05 |
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
App 20060079525 - Ancliff; Rachael Anne ; et al. | 2006-04-13 |
Novel compounds
App 20060063765 - Ancliff; Rachael Ann ; et al. | 2006-03-23 |
N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions
App 20060058299 - Ancliff; Rachael Ann ; et al. | 2006-03-16 |
Compounds
App 20060019964 - Ancliff; Ranchael Ann ; et al. | 2006-01-26 |
Compounds useful in the treatment of inflammatory diseases
App 20040058907 - Ancliff, Rachael Anne ; et al. | 2004-03-25 |
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
App 20040058923 - Ancliff, Rachael Anne ; et al. | 2004-03-25 |
Anti-atherosclerotic diaryl compounds
Grant 5,776,951 - Arrowsmith , et al. July 7, 1 | 1998-07-07 |
| 